Lanreotide
Drug timelines are a Plus or Pro feature.
24 regulatory and trial events tracked for Lanreotide, covering 2009-02-17 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study